PURPOSE: Apoptosis pathway, gastroesophageal reflux symptoms (reflux), higher body mass index (BMI), and tobacco smoking have been individually associated with esophageal adenocarcinoma (EA) development. However, how multiple factors jointly affect EA risk remains unclear. PATIENTS AND METHODS: In total, 305 patients with EA and 339 age- and sex-matched controls were studied. High-order interactions among reflux, BMI, smoking, and functional polymorphisms in five apoptotic genes (FAS, FASL, IL1B, TP53BP, and BAT3) were investigated by entropy-based multifactor dimensionality reduction (MDR), classification and regression tree (CART), and traditional logistic regression (LR) models. RESULTS: In LR analysis, reflux, BMI, and smoking were significantly associated with EA risk, with reflux as the strongest individual factor. No individual single nucleotide polymorphism was associated with EA susceptibility. However, there was a two-way interaction between IL1B + 3954C>T and reflux (P = .008). In both CART and MDR analyses, reflux was also the strongest individual factor for EA risk. In individuals with reflux symptoms, CART analysis indicated that strongest interaction was among variant genotypes of IL1B + 3954C>T and BAT3S625P, higher BMI, and smoking (odds ratio [OR], 5.76; 95% CI, 2.48 to 13.38), a finding independently found using MDR analysis. In contrast, for participants without reflux symptoms, the strongest interaction was found between higher BMI and smoking (OR, 3.27; 95% CI, 1.88 to 5.68), also echoed by entropy-based MDR analysis. CONCLUSION: Although a history of reflux is an important risk for EA, multifactor interactions also play important roles in EA risk. Gene-environment interaction patterns differ between patients with and without reflux symptoms.
PURPOSE: Apoptosis pathway, gastroesophageal reflux symptoms (reflux), higher body mass index (BMI), and tobacco smoking have been individually associated with esophageal adenocarcinoma (EA) development. However, how multiple factors jointly affect EA risk remains unclear. PATIENTS AND METHODS: In total, 305 patients with EA and 339 age- and sex-matched controls were studied. High-order interactions among reflux, BMI, smoking, and functional polymorphisms in five apoptotic genes (FAS, FASL, IL1B, TP53BP, and BAT3) were investigated by entropy-based multifactor dimensionality reduction (MDR), classification and regression tree (CART), and traditional logistic regression (LR) models. RESULTS: In LR analysis, reflux, BMI, and smoking were significantly associated with EA risk, with reflux as the strongest individual factor. No individual single nucleotide polymorphism was associated with EA susceptibility. However, there was a two-way interaction between IL1B + 3954C>T and reflux (P = .008). In both CART and MDR analyses, reflux was also the strongest individual factor for EA risk. In individuals with reflux symptoms, CART analysis indicated that strongest interaction was among variant genotypes of IL1B + 3954C>T and BAT3S625P, higher BMI, and smoking (odds ratio [OR], 5.76; 95% CI, 2.48 to 13.38), a finding independently found using MDR analysis. In contrast, for participants without reflux symptoms, the strongest interaction was found between higher BMI and smoking (OR, 3.27; 95% CI, 1.88 to 5.68), also echoed by entropy-based MDR analysis. CONCLUSION: Although a history of reflux is an important risk for EA, multifactor interactions also play important roles in EA risk. Gene-environment interaction patterns differ between patients with and without reflux symptoms.
Authors: Kylie J Smith; Suzanne M O'Brien; B Mark Smithers; David C Gotley; Penelope M Webb; Adèle C Green; David C Whiteman Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-11 Impact factor: 4.254
Authors: W H Chow; W J Blot; T L Vaughan; H A Risch; M D Gammon; J L Stanford; R Dubrow; J B Schoenberg; S T Mayne; D C Farrow; H Ahsan; A B West; H Rotterdam; S Niwa; J F Fraumeni Journal: J Natl Cancer Inst Date: 1998-01-21 Impact factor: 13.506
Authors: Silvia Delgado-Aros; G Richard Locke; Michael Camilleri; Nicholas J Talley; Sara Fett; Alan R Zinsmeister; L Joseph Melton Journal: Am J Gastroenterol Date: 2004-09 Impact factor: 10.864
Authors: Rhonda F Souza; Kenneth Shewmake; Stephanie Pearson; George A Sarosi; Linda A Feagins; Ruben D Ramirez; Lance S Terada; Stuart J Spechler Journal: Am J Physiol Gastrointest Liver Physiol Date: 2004-07-01 Impact factor: 4.052
Authors: William D Hazelton; Kit Curtius; John M Inadomi; Thomas L Vaughan; Rafael Meza; Joel H Rubenstein; Chin Hur; E Georg Luebeck Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-04-30 Impact factor: 4.254
Authors: James Y Dai; Jean de Dieu Tapsoba; Matthew F Buas; Lynn E Onstad; David M Levine; Harvey A Risch; Wong-Ho Chow; Leslie Bernstein; Weimin Ye; Jesper Lagergren; Nigel C Bird; Douglas A Corley; Nicholas J Shaheen; Anna H Wu; Brian J Reid; Laura J Hardie; David C Whiteman; Thomas L Vaughan Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-09-16 Impact factor: 4.254
Authors: Rihong Zhai; Yongyue Wei; Li Su; Geoffrey Liu; Mathew H Kulke; John C Wain; David C Christiani Journal: Carcinogenesis Date: 2014-11-08 Impact factor: 4.944
Authors: I-Chen Wu; Yang Zhao; Rihong Zhai; Chen-yu Liu; Feng Chen; Monica Ter-Minassian; Kofi Asomaning; Li Su; Rebecca S Heist; Matthew H Kulke; Geoffrey Liu; David C Christiani Journal: Carcinogenesis Date: 2011-01-06 Impact factor: 4.944
Authors: I-Chen Wu; Yang Zhao; Rihong Zhai; Geoffrey Liu; Monica Ter-Minassian; Kofi Asomaning; Li Su; Chen-Yu Liu; Feng Chen; Matthew H Kulke; Rebecca S Heist; David C Christiani Journal: Neoplasia Date: 2011-04 Impact factor: 5.715
Authors: Mary Zhang; Aarti Mathur; Yuwei Zhang; Sichuan Xi; Scott Atay; Julie A Hong; Nicole Datrice; Trevor Upham; Clinton D Kemp; R Taylor Ripley; Gordon Wiegand; Itzak Avital; Patricia Fetsch; Haresh Mani; Daniel Zlott; Robert Robey; Susan E Bates; Xinmin Li; Mahadev Rao; David S Schrump Journal: Cancer Res Date: 2012-07-02 Impact factor: 12.701